Nymox Pharmaceautical Corporation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nymox Pharmaceautical Corporation

NYMXF 0.106

0.0%

Oct 31 9:30 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext

To: Apple Jacks who wrote (18)	4/22/2000 6:37:00 PM
From: posthumousone	of 28

comments on how this will effect hte stock?? Novartis AG Gets FDA OK To Market Exelon Dow Jones Newswires EAST HANOVER, N.J. -- Novartis AG's (Z.NOV) Novartis Pharmaceuticals Corp. received Food and Drug Administration approval to market Exelon, a cholinesterase inhibitor for the treatment of patients with mild to moderate Alzheimer's disease. In a press release Friday, the company said Exelon is now cleared for marketing in nearly 70 countries. -Bill Platt; Dow Jones Newswires; 201-938-5400

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext